ASGE and AGA Publish Statements on IBD-Related Dysplasia Treatment

ASGE and AGA Publish Statements on IBD-Related Dysplasia Treatment
The American Society for Gastrointestinal Endoscopy (ASGE) and the American Gastroenterological Association (AGA) released a series of recommendations regarding dysplasia associated with inflammatory bowel disease (IBD). The document published in the journal GIE: Gastrointestinal Endoscopy and Gastroenterology aims to improve and standardize the methods of surveillance and management of the condition. The document is meant to be a statement of consensus about the treatment and diagnosis of dysplasia. Ulcerative colitis and Crohn's disease, the two most common forms of IBD, are diseases that develop in the region of the colon and increase the risk of suffering from colorectal cancer, which are thought to emerge from dysplasia areas, or abnormal cellular alterations in the colon mucosa. The diagnosis of the condition is usually made with mucosa examination through the conduction of targeted biopsies in the visible lesions, as well as extensive random biopsies to search for invisible dysplasia. However, the two associations want to modernize procedures, as current endoscopy technologies enable the visibility of most dysplasia, as announced in a press release. "In the field of gastrointestinal endoscopy, we are fortunate to have new types of equipment and technology that provide high-definition visualization of the colon," said ASGE President Colleen M. Schmitt, MD, MPH, FASGE. "In addition, gastrointestinal endoscopists are continually updating their skills to stay abreast of the latest techniques for surveillance, as well removal of lesions. These procedures contribute greatly to the evolving ability of the health care team to help patients with IBD achieve optimal health and minimize their risk for colon cancer." The new recommendations include ni
Subscribe or to access all post and page content.